Vitalhub (TSE:VHI) Given a C$15.00 Price Target at Stifel Nicolaus

Key Points

• Vitalhub (TSE:VHI) has received a target price of C$15.00 from Stifel Nicolaus, indicating a potential upside of 41.38% from its current stock price.
• Several other brokerages have also set price targets for Vitalhub, with the consensus average target at C$14.86 and most analysts giving it a "Buy" rating.
• Two directors recently sold shares of Vitalhub, indicating a significant decrease in their ownership positions. Danny Matlow sold 150,000 shares, while Steve Garrington sold 20,000 shares.

Vitalhub (TSE:VHI - Get Free Report) has been given a C$15.00 target price by equities research analysts at Stifel Nicolaus in a note issued to investors on Wednesday,BayStreet.CA reports. The firm currently has a "buy" rating on the stock. Stifel Nicolaus' target price points to a potential upside of 41.38% from the company's current price.

A number of other brokerages have also issued reports on VHI. National Bankshares set a C$16.00 price target on shares of Vitalhub and gave the stock an "outperform" rating in a report on Thursday, August 21st. Scotiabank raised their price target on shares of Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a report on Friday, June 20th. Royal Bank Of Canada set a C$15.00 target price on shares of Vitalhub and gave the company a "moderate buy" rating in a research note on Thursday, September 18th. Raymond James Financial lifted their target price on shares of Vitalhub from C$14.50 to C$15.00 and gave the company an "outperform" rating in a research note on Tuesday, August 12th. Finally, TD Securities lifted their target price on shares of Vitalhub from C$15.00 to C$16.00 and gave the company a "buy" rating in a research note on Monday, August 11th. One analyst has rated the stock with a Strong Buy rating and seven have issued a Buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Buy" and a consensus target price of C$14.86.

Vitalhub Stock Performance

Shares of VHI stock traded down C$0.02 on Wednesday, hitting C$10.61. 165,873 shares of the company's stock traded hands, compared to its average volume of 150,013. The stock has a market capitalization of C$666.63 million, a price-to-earnings ratio of 132.63, a P/E/G ratio of 1.18 and a beta of 0.62. Vitalhub has a one year low of C$8.50 and a one year high of C$14.64. The company's fifty day simple moving average is C$11.95 and its 200 day simple moving average is C$11.34.

Insider Transactions at Vitalhub

In related news, Director Danny Matlow sold 150,000 shares of Vitalhub stock in a transaction dated Thursday, August 28th. The shares were sold at an average price of C$12.75, for a total transaction of C$1,912,500.00. Following the completion of the transaction, the director directly owned 520,001 shares of the company's stock, valued at C$6,630,012.75. This trade represents a 22.39% decrease in their position. Also, Director Steve Garrington sold 20,000 shares of Vitalhub stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of C$12.90, for a total transaction of C$258,000.00. Following the transaction, the director directly owned 60,000 shares of the company's stock, valued at approximately C$774,000. This trade represents a 25.00% decrease in their ownership of the stock. Company insiders own 18.57% of the company's stock.

About Vitalhub

Vitalhub Corp is Canada-based firm that develops technology solutions for health and human services providers in the mental health (child through adult), long term care, community health service, home health, social service, and acute care sectors. Its technologies include blockchain, mobile, patient flow, web-based assessment, and electronic health record solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.